Today is #WorldALLDay, an opportunity to raise awareness of acute lymphoblastic leukemia (ALL) and the ongoing need for innovation on behalf of patients and families.
According to @AmericanCancer an estimated over 6,000 new cases of ALL will be diagnosed in the U.S. in 2026,
Transforming allogeneic cell therapy for patients with blood cancer and autoimmune diseases

